Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study

Media reports have caused a significant drop in confidence in the AstraZeneca ChAdOx1 nCoV-19 COVID-19 vector vaccine (Vaxzevria, AstraZeneca Södertälje, Sweden). This has caused many people, already vaccinated with the first dose of AstraZeneca, to refuse vaccination with this product. On the other...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukaszuk, Krzysztof, Podolak, Amira, Malinowska, Paulina, Lukaszuk, Jakub, Jakiel, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028987/
https://www.ncbi.nlm.nih.gov/pubmed/35455270
http://dx.doi.org/10.3390/vaccines10040521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028987/
https://www.ncbi.nlm.nih.gov/pubmed/35455270
http://dx.doi.org/10.3390/vaccines10040521

Ejemplares similares